Raffi Asadorian, Chief Financial Officer at ACELRX PHARMACEUTICALS INC (ACRX), bought 5,000 shares at $1.94 ($10K) on 2017-11-13, disclosed to the SEC on 2017-11-14.
Open-market purchase of $10k ACRX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| ACRX | BUY | 2019-03-04 | $10K | — | Filing → |
| ACRX | BUY | 2018-12-17 | $14K | — | Filing → |
| ACRX | BUY | 2018-11-13 | $16K | — | Filing → |